Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, and Parallel Groups, Placebo-controlled Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain.

NCT02254525 is registered in ClinicalTrials.gov with Biomendi S.A.U. as lead sponsor.

NCT NCT02254525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02254525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, and Parallel Groups, Placebo-controlled Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain.
Lead sponsor
Biomendi S.A.U.
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2012
Completion date
July 31, 2014
Enrollment
231 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain